Denali Therapeutics (DNLI) Stock Price & Financial Analysis
Denali Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Denali Therapeutics
What is the current stock price for DNLI?
As of the latest trading session, DNLI stock trades at $24.77. The 52-week range is $12.58–$25.31, with a day range of $23.51–$25.31.
What is the P/E ratio for DNLI?
The P/E ratio (Price-to-Earnings) for DNLI is shown in the Key Statistics section. This valuation metric helps compare Denali Therapeutics Inc. to industry peers.
Does DNLI pay dividends?
Denali Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for DNLI?
Based on 17 analysts, the consensus for DNLI is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of DNLI?
Denali Therapeutics's market capitalization is $4.62B, classifying it as a mid-cap company. Denali Therapeutics operates in the Healthcare sector within the Biotechnology industry.